Država: Irska
Jezik: angleščina
Source: HPRA (Health Products Regulatory Authority)
Perindopril tosilate; Indapamide
Teva Pharma B.V.
C09BA; C09BA04
Perindopril tosilate; Indapamide
2.5 mg/0.625 milligram(s)
Film-coated tablet
Product subject to prescription which may be renewed (B)
ACE inhibitors and diuretics; perindopril and diuretics
Marketed
2013-02-22
Perindopril tosilate/indapamide 2.5 mg/0.625 mg, NL/H/2467/001, 16.05.2022 Perindopril tosilate/indapamide 2.5 mg/0.625 mg, NL/H/2467/001, 19.01.2023 Day 20 second round: shaded in turquoise PACKAGE LEAFLET: INFORMATION FOR THE USER PERINDOPRIL TOSILATE/INDAPAMIDE TEVA 2.5 MG/0.625 MG FILM-COATED TABLETS perindopril tosilate/indapamide READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Perindopril tosilate/indapamide Teva is and what it is used for 2. What you need to know before you take Perindopril tosilate/indapamide Teva 3. How to take Perindopril tosilate/indapamide Teva 4. Possible side effects 5. How to store Perindopril tosilate/indapamide Teva 6. Contents of the pack and other information 1. WHAT [PRODUCT NAME] IS AND WHAT IT IS USED FOR WHAT IS PERINDOPRIL TOSILATE/INDAPAMIDE TEVA ? Perindopril tosilate/indapamide Teva is a combination of two active ingredients, perindopril and indapamide. It is an anti-hypertensive and is used in the treatment of high blood pressure (hypertension) in adults. WHAT IS PERINDOPRIL TOSILATE/INDAPAMIDE TEVA USED FOR? Perindopril belongs to a class of medicines called ACE inhibitors. These work by widening the blood vessels, which makes it easier for your heart to pump blood through them. Indapamide is a diuretic. Diuretics increase the amount of urine produced by the kidneys. However, indapamide is different from other diuretics, as it only causes a slight increase in the amount of urine produced. Each of the active ingredients reduces blood pressure and they Preberite celoten dokument
Health Products Regulatory Authority 23 February 2023 CRN00D4Z6 Page 1 of 20 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Perindopril tosilate/Indapamide Teva 2.5 mg/0.625 mg Film-coated tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains 1.704 mg perindopril corresponding to 2.5 mg perindopril tosilate, converted _in situ _ to perindopril sodium, and 0.625 mg indapamide. Excipient with known effect: Each film-coated tablet contains 74.056 mg lactose monohydrate. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Film-coated tablet White, capsule shaped biconvex film-coated tablet of approx. 4 mm width and 8 mm length, debossed breakline on one side and plain on the other side. The score line is only to facilitate breaking for ease of swallowing and not to divide into equal doses. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Essential hypertension. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology The usual dose is one Perindopril tosilate/indapamide Teva 2.5mg/0.625mg film-coated tablet per day as a single dose, preferably to be taken in the morning and before a meal. If blood pressure is not controlled after one month of treatment, the dose can be doubled. Special populations _Elderly (see section 4.4)_ Treatment should be started at the normal dose of one Perindopril tosilate/indapamide Teva 2.5mg/0.625mg film-coated tablet per day. _Renal impairment (see section 4.4)_ In severe renal impairment (creatinine clearance below 30 ml/min), treatment is contraindicated. In patients with moderate renal impairment (creatinine clearance 30-60 ml/min), the maximum dose should be one tablet of Perindopril tosilate/indapamide Teva 2.5mg/0.625mg per day. In patients with creatinine clearance greater than or equal to 60 ml/min, no dose modification is required. Usual medical follow-up will include frequent monitoring of creatinine and potassium. _Hepatic impairment (see sections 4.3, 4.4 and 5.2)_ In severe hepatic impairment, treatment is con Preberite celoten dokument